Roll-over Study to Allow Continued Access to Ribociclib
Public ClinicalTrials.gov record NCT05161195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment in Novartis-sponsored Study
Study identification
- NCT ID
- NCT05161195
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 134 participants
Conditions and interventions
Conditions
Interventions
- Anastrozole Drug
- Fulvestrant Drug
- Goserelin Drug
- Letrozole Drug
- Ribociclib Drug
- Tamoxifen Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 6, 2022
- Primary completion
- Jun 27, 2030
- Completion
- Aug 13, 2030
- Last update posted
- Apr 1, 2026
2022 – 2030
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer and Research Centers | Chandler | Arizona | 85224 | — |
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | — |
| Poudre Valley Hospital | Fort Collins | Colorado | 80528 | — |
| Mid Florida Hematology And Onc Ctr | Orange | Florida | 32763 | — |
| Summit Cancer Care | Savannah | Georgia | 31405 | — |
| John D Archbold Memorial Hospital | Thomasville | Georgia | 31792 | — |
| Duly Health and Care | Plainfield | Illinois | 60585 | — |
| Indian Univ Health Goshen Center forCancer | Goshen | Indiana | 46526 | — |
| Northern Light Mercy Hospital | Portland | Maine | 04102 | — |
| Englewood Health | Englewood | New Jersey | 07631 | — |
| The Valley Hospital-Luckow Pavillion | Paramus | New Jersey | 07652 | — |
| Eastchester Center for Cancer Care | The Bronx | New York | 10469 | — |
| University Hospitals of Cleveland Seidman Cancer Center | Cleveland | Ohio | 44106 | — |
| Oklahoma Cancer Specialists and Research Institute | Tulsa | Oklahoma | 74136 | — |
| Millennium Research Clin Develop | Houston | Texas | 77090 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05161195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05161195 live on ClinicalTrials.gov.